New microscope uses photonics for insights into ‘superbugs’
Scientists are building a new super-resolution microscope that uses laser light to study the inner workings and behaviours of superbugs to gain new insights into how they cause disease.
The microscope will allow scientists to...
Shaping the science of oncology
Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first and best-in-class cancer drugs.
From the day that Dr McLaughlin –...
Biotech pioneer tackles the biology of ageing
Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen...
Euro biotech: breaking down the barriers to a golden age
Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality.
Europe’s tech sector is going from strength to strength....
Biosample provenance: what researchers need to know
Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates.
The journey for every biospecimen used for...
Ultrapure water system passes big test
An innovative ultrapure water system has successfully tapped into healthcare diagnostics.
The pharmaceutical industry is embracing new technology that can reduce costs and simplify installation. At the production site of a multinational healthcare diagnostic test...
Protecting Digital Medtech Innovation
For many years the medical technology (medtech) sector has been at the forefront of innovation and the Covid-19 pandemic has not slowed it down, with new technology quickly being developed to test for, prevent...
The scientific, political and economic implications of COVID-19: an insider’s perspective
It is widely assumed that the life science industry performed well off the back of the COVID-19 pandemic, with the demand for assays and molecular tools driving unprecedented sales to support global research. This...
SAGES TEACH THE ART OF ADAPTING TO CLIMATE CHANGE
While the conversation about climate change has been dominated by mitigation, what is equally crucial is the need to adapt to the unavoidable changes already on their way. “We have absolutely no choice but...
TWO NEW FORMS OF THERAPY GIVE HOPE WHEN BLOOD CANCER RETURNS AND BOWEL CANCER...
Scientists trial new way to boost CAR T-cell therapy
Cancer Research UK is collaborating with Aleta Biotherapeutics to trial a new therapy that reboots a treatment for some people whose blood cancer starts to come back.
The new...
A transformative roadmap for neurotechnology in the UK
Innovation experts, KTN, publish roadmap calling for multi-million pound investment to develop and commercialise ground-breaking treatments for disorders of the brain and nervous system.
The human brain remains one of the great unknown frontiers and...
3D PRINTED LIVER AIDS LIFE SAVING SURGERY
Surgeons will perform liver resections with greater accuracy and deliver improved patient outcomes thanks to new research by Nottingham Trent University. Senior research fellow Richard Arm has developed a way to 3D-print scan data...
£7m invested in fight against antimicrobial resistance
Phico Therapeutics Ltd, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has announced £7m in new investment.
The financing was led by growth...
Genome sequencing reveals how salmonella carves out a niche in pork production
Variants of concern (VOCs) and variants of interest (VOIs) have become familiar terms due to the current pandemic, but variants of familiar pathogens such as salmonella also present a threat to human and animal...
UK ‘Octopus’ trial tackling multiple sclerosis is a world first
A ground breaking mega-trial for progressive multiple sclerosis will be launched in the UK later this year.
Octopus, so called because of its multiple arms, is a revolutionary clinical trial that will transform the way...
The Nagoya Protocol and the UK – Are you Compliant?
The Nagoya Protocol has been in force in the UK since October 2015 and obliges users of genetic resources and traditional knowledge associated with genetic resources to comply with due diligence requirements before its...